Search Tag: Glucose-lowering therapy

Cardiology Management

Personalising glucose-lowering therapy in Type 2 Diabetes and CVD patients

2018 21 Mar

Type 2 diabetes mellitus (T2DM) is a complex disease with a pathogenesis that is multidimensional. Recently, several specific glucose-lowering agents have been demonstrated to improve cardiovascular outcomes and may be favoured in T2DM patients with coexisting cardiovascular disease (CVD), according to a review paper in the journal Endocrinology and... Read more